- Home
- ITRG vs MAIA Comparison
ITRG vs MAIA Comparison
Compare ITRG & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- MAIA
- Stock Information
- Founded
- ITRG 1997
- MAIA 2018
- Country
- ITRG Canada
- MAIA United States
- Employees
- ITRG N/A
- MAIA N/A
- Industry
- ITRG Precious Metals
- MAIA Biotechnology: Pharmaceutical Preparations
- Sector
- ITRG Basic Materials
- MAIA Health Care
- Exchange
- ITRG Nasdaq
- MAIA Nasdaq
- Market Cap
- ITRG 84.2M
- MAIA 62.4M
- IPO Year
- ITRG N/A
- MAIA 2022
- Fundamental
- Price
- ITRG $1.20
- MAIA $2.82
- Analyst Decision
- ITRG Strong Buy
- MAIA
- Analyst Count
- ITRG 1
- MAIA 0
- Target Price
- ITRG $3.75
- MAIA N/A
- AVG Volume (30 Days)
- ITRG 259.4K
- MAIA 60.0K
- Earning Date
- ITRG 11-12-2024
- MAIA 11-05-2024
- Dividend Yield
- ITRG N/A
- MAIA N/A
- EPS Growth
- ITRG N/A
- MAIA N/A
- EPS
- ITRG N/A
- MAIA N/A
- Revenue
- ITRG N/A
- MAIA N/A
- Revenue This Year
- ITRG N/A
- MAIA N/A
- Revenue Next Year
- ITRG $360.53
- MAIA N/A
- P/E Ratio
- ITRG N/A
- MAIA N/A
- Revenue Growth
- ITRG N/A
- MAIA N/A
- 52 Week Low
- ITRG $0.64
- MAIA $0.82
- 52 Week High
- ITRG $1.28
- MAIA $5.99
- Technical
- Relative Strength Index (RSI)
- ITRG 66.49
- MAIA 50.98
- Support Level
- ITRG $0.95
- MAIA $2.36
- Resistance Level
- ITRG $1.28
- MAIA $2.72
- Average True Range (ATR)
- ITRG 0.07
- MAIA 0.22
- MACD
- ITRG 0.01
- MAIA 0.02
- Stochastic Oscillator
- ITRG 77.27
- MAIA 72.28
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of highly prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.